None of the three light treatments won for moderate-to-severe inflammatory acne in the 2026 pilot. Intense pulsed light (IPL), pulsed-dye laser (PDL), and Q-switched 1064-nm Nd:YAG improved to a similar degree, so larger trials must confirm the tie.
The three-arm randomized trial assigned 36 patients with moderate-to-severe inflammatory acne to IPL, PDL, or Q-switched 1064-nm Nd:YAG, according to the U.S. National Library of Medicine PubMed trial summary. Use the sections below to match your main concern — lasting redness, deep oil-gland breakouts, or treatment burden — to the right question for your dermatologist.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did the pilot actually show?
- How do IPL, PDL and Nd:YAG differ?
- How safe are these options, and what do guidelines say?
- How should you choose with your dermatologist?
What did the pilot actually show?
Lesion counts and severity scores showed no significant between-group differences at any session, with P values of 0.06–0.92, according to the PubMed summary. Each group improved significantly from baseline, and disability scores fell.
The small size limits the meaning. With about 12 patients per arm and short follow-up, the trial is underpowered as a pilot and cannot prove equivalence. Larger multicenter trials are needed to test comparative efficacy and safety.
How do IPL, PDL and Nd:YAG differ?
PDL and IPL act near the surface. PDL at 585/595 nm targets oxyhemoglobin to reduce vascularity and inflammation in red lesions, while IPL uses broad 400–1200 nm light targeting porphyrins and hemoglobin for mild-to-moderate inflammatory acne, according to the World Journal of Advanced Research and Reviews mechanism review.
Long-pulsed 1064-nm Nd:YAG reaches deeper. It heats sebaceous glands, reduces sebum, normalizes keratinization, raises TGF-beta, and lowers IL-8, TLR-2, TNF-alpha and MMP-9, according to the Springer Lasers in Medical Science review.
- PDL: best match for redness and visible vessels in erythematous lesions.
- IPL: broad light for scattered inflammatory papules and pustules plus redness.
- Nd:YAG: deeper reach for sebaceous disease and better tolerance in darker skin.
How safe are these options, and what do guidelines say?
Safety was generally favorable with mainly transient redness. A 34-patient split-face study of PDL versus Nd:YAG reported equal lesion reduction, with erythema as the commonest effect, according to the Laser and Health Academy summary of the peer-reviewed study.
Routine use is still not firmly endorsed. American Academy of Dermatology guidance reported via MDedge 2024 acne update judged evidence for light and laser devices insufficient for routine recommendation and called for large prospective multicenter randomized blinded trials versus placebo. FDA 510(k) clearances already cover IPL systems for mild-to-moderate and moderate inflammatory acne, according to FDA via Innolitics, so use is permitted while comparative claims await stronger data.
How should you choose with your dermatologist?
Match the device to the dominant target. Device choice turns on redness and vascularity for PDL, deeper sebaceous disease and darker-skin tolerance for Nd:YAG, plus sessions needed, cost, and adjunctive standard therapy, according to Practical Dermatology reporting on laser mechanisms. Bring phone photos of flares, a list of current acne prescriptions, and notes on prior redness or dark spots to that visit.
- Track whether redness, deep painful bumps, or both dominate flares.
- Ask how many sessions, what interval, what aftercare, and what added retinoid, benzoyl peroxide, or hormonal therapy is planned.
- Ask about pain, temporary redness, pigment change risk for your skin tone, and total cost.